TREA

79354840 - VELOXTAR

Follow

Information

  • Trademark
  • 79354840
  • Serial Number
    79354840
  • Filing Date
    June 24, 2022
    a year ago
  • Transaction Date
    April 10, 2024
    22 days ago
  • Status Date
    February 09, 2024
    2 months ago
  • Published for Opposition Date
    January 23, 2024
    3 months ago
  • Location Date
    December 20, 2023
    4 months ago
  • Status Code
    802
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MESSICK, TABITHA LEE
  • Attorney Docket Number
    S26758
    Attorney Name
    Leigh Ann Lindquist
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
VELOXTAR
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals; custom manufacture of oral medicinal preparations in the form of tablets; custom manufacture of orally disintegrating tablet; providing information relating to custom manufacturing or processing of pharmaceuticals; printing, custom stamping and surface coating of medicinal preparations in the form of tablets; providing information relating to material treatment
  • GS0051: Medicinal preparations in the form of orally disintegrating tablets for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; oral medicinal preparations in the form of tablets for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; oral medicinal preparations in the form of compressed tablets for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; drug delivery agents in the form of tablets that provide controlled release of the active pharmaceutical ingredients in a wide variety; chemical preparations for medical purposes for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; pharmaceutical preparations for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; pharmaceutical agents for dispensing purposes for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; pharmaceutical substances for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary
  • GS0421: Research, development and testing of disintegrants for tablets and orally disintegrating tablets using the disintegrants; research, development and testing of rapidly disintegrating tablets and its manufacturing methods; testing of medicines; research and development of medicines; testing, inspection or research of medicines cosmetics or foods; chemical research; testing of chemicals; inspection in the field of chemistry for quality control purposes; scientific laboratory services; research and development of new products for others
Case File Event Statements
  • 4/10/2024 - 22 days ago
    22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 4/10/2024 - 22 days ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 2/9/2024 - 2 months ago
    20 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 1/23/2024 - 3 months ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/23/2024 - 3 months ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/22/2024 - 3 months ago
    17 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/3/2024 - 4 months ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/3/2024 - 4 months ago
    15 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/3/2024 - 4 months ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/16/2023 - 4 months ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/7/2023 - 4 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/7/2023 - 4 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/7/2023 - 4 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/26/2023 - 10 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/7/2023 - 11 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/7/2023 - 11 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/19/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/18/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/9/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/18/2022 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/14/2022 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/10/2022 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR